VIVO - Meridian Bioscience - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

VIVO is currently covered by 1 analysts with an average price target of $1.95. This is a potential upside of $1.95 (0%) from yesterday's end of day stock price of $0.

Meridian Bioscience's activity chart (see below) currently has 30 price targets and 22 ratings on display. The stock rating distribution of VIVO is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.67% with an average time for these price targets to be met of 356.25 days.

Highest price target for VIVO is $33, Lowest price target is $33, average price target is $1.95.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 08-Jul-2022. First documented stock forecast 04-May-2015.

Best performing analysts who are covering VIVO - Meridian Bioscience:

Yi Chen Steven Mah William Quirk Mark Massaro

Currently out of the existing stock ratings of VIVO, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

30

$-3.97 (-11.69%)

30

1 years 8 months 20 days ago

6/9 (66.67%)

$-3 (-9.09%)

337

Buy

34

$0.03 (0.09%)

34

3 years 1 months 5 days ago

3/5 (60%)

$12.77 (60.15%)

96

Sell

15

$-18.97 (-55.84%)

15

4 years 10 months 27 days ago

4/4 (100%)

$0.32 (2.35%)

447

Sell

11

4 years 10 months 27 days ago

4/4 (100%)

$-2.29 (-17.23%)

545

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VIVO (Meridian Bioscience) average time for price targets to be met?

On average it took 356.25 days on average for the stock forecasts to be realized with a an average price target met ratio 81.67

Which analyst has the current highest performing score on VIVO (Meridian Bioscience) with a proven track record?

YI CHEN

Which analyst has the current lower performing score on VIVO (Meridian Bioscience) with a proven track record?

MARK MASSARO

Which analyst has the most public recommendations on VIVO (Meridian Bioscience)?

Yi Chen has 24 price targets and 15 ratings on VIVO

Which analyst is the currently most bullish on VIVO (Meridian Bioscience)?

Steven Mah with highest potential upside - $0.03

Which analyst is the currently most reserved on VIVO (Meridian Bioscience)?

William Quirk with lowest potential downside - -$18.97

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?